<SUBMISSION>
<ACCESSION-NUMBER>0001193125-06-151750
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20060721
<ITEMS>5.02
<ITEMS>9.01
<FILING-DATE>20060724
<DATE-OF-FILING-DATE-CHANGE>20060724
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AtriCure, Inc.
<CIK>0001323885
<ASSIGNED-SIC>3841
<IRS-NUMBER>341940305
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-51470
<FILM-NUMBER>06976762
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>6033 SCHUMACHER PARK DRIVE
<CITY>WEST CHESTER
<STATE>OH
<ZIP>45069
<PHONE>513-755-4107
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>6033 SCHUMACHER PARK DRIVE
<CITY>WEST CHESTER
<STATE>OH
<ZIP>45069
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML><HEAD>
<TITLE>Current Report</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:3px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="3"><B>PURSUANT TO SECTION 13 OR 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>SECURITIES EXCHANGE ACT OF 1934 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Date of Report (Date of earliest event reported): July&nbsp;21, 2006 </B></FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>AtriCure, Inc. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR
WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>000-51470</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>34-1940305</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>6033 Schumacher Park Drive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>West Chester, OH</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>45069</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code: (513)&nbsp;755-4100 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or
former address, if changed since last report) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal
Officers. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On July&nbsp;24, 2006, we announced that Thomas J. Etergino resigned as our Vice President and Chief Financial Officer. We
expect Mr.&nbsp;Etergino to stay through August&nbsp;18, 2006, at which point he will leave to pursue other endeavors. Until Mr.&nbsp;Etergino&#146;s successor is named, David J. Drachman, our President and Chief Executive Officer, will work with
our controller to manage our finances. All finance functions will report directly to Mr.&nbsp;Drachman. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">A copy of the press release
announcing Mr.&nbsp;Etergino&#146;s resignation is attached as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2"><B>Item&nbsp;9.01. Financial Statements and Exhibits. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">(d) Exhibits. </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="1"><B>No.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of AtriCure, Inc. dated as of July 24, 2006.</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">ATRICURE, INC.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1px;border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="2">/s/ David J. Drachman</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">David J. Drachman</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Dated: July&nbsp;24, 2006 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>EXHIBIT LIST </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="1"><B>No.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of AtriCure, Inc. dated as of July 24, 2006.</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px">

<IMG SRC="g28007img.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Contacts: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><I>AtriCure</I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">David J. Drachman</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(513) 755-5758</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">ddrachman@atricure.com</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><I>The Ruth Group</I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Stephanie Carrington / Nick
Laudico (investors)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(646) 536-7017 / 7030</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">scarrington@theruthgroup.com</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">nlaudico@theruthgroup.com</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Jason Rando (media)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(646) 536-7025</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">jrando@theruthgroup.com</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Press Release </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>AtriCure Announces Resignation of Chief Financial Officer - </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Thomas J. Etergino </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>WEST CHESTER, Ohio, July&nbsp;24, 2006 </B>&#151; AtriCure, Inc. (Nasdaq: ATRC), a medical device company focused on developing, manufacturing and selling innovative
surgical devices, announced today that Thomas J. Etergino resigned as the Company&#146;s Vice President and Chief Financial Officer. The Company expects Mr.&nbsp;Etergino to stay through August&nbsp;18, 2006, at which point he will leave to pursue
other endeavors. Until Mr.&nbsp;Etergino&#146;s successor is named, David J. Drachman, President and Chief Executive Officer, will work with the Company&#146;s controller to manage the Company&#146;s finances. All finance functions will report
directly to Mr.&nbsp;Drachman. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Dave Drachman, President and CEO, said, &#147;Tom has led a strong finance team here at AtriCure. With its depth and
experience, we expect this team will ensure a smooth and orderly transition through his departure and eventual replacement. This dedicated team remains focused on achieving our long-term financial goals. We appreciate the contributions Tom has made
while at AtriCure and wish him well in his future endeavors.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2"><U>About AtriCure, Inc. </U></FONT></P> <P
STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft and
cardiac tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably
create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a rapid, irregular quivering of the upper chambers of the heart. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">This press release contains &#147;forward-looking statements&#148; within the meaning of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements include statements that address activities, events or developments that AtriCure expects, believes or anticipates will or may occur in the future, such as earnings estimates, other
predictions of financial performance, launches by AtriCure of new products and market acceptance of AtriCure&#146;s products. Forward-looking statements are based on AtriCure&#146;s experience and perception of current conditions, trends, expected
future developments and other factors it believes are appropriate under the circumstances and are subject to numerous risks and uncertainties, many of which are beyond AtriCure&#146;s control. These risks and uncertainties include the rate and
degree of market acceptance of AtriCure&#146;s products, AtriCure&#146;s ability to develop and market new and enhanced products, the timing of and ability to obtain and maintain regulatory clearances and approvals for its products, the timing of
and ability to obtain reimbursement of procedures utilizing AtriCure&#146;s products, competition from existing and new products and procedures or AtriCure&#146;s ability to effectively react to other risks and uncertainties described from time to
time in AtriCure&#146;s SEC filings, such as fluctuation of quarterly financial results, reliance on third party manufacturers and suppliers, litigation or other proceedings, government regulation and stock price volatility. AtriCure does not
guarantee any forward-looking statement, and actual results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or
otherwise. </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g28007img.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g28007img.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`2P$#`P$1``(1`0,1`?_$`-$```$%``,!`0``````
M```````&!P@)"@$$!0,"`0$``00#`0```````````````@$#!0@$!@<)$```
M!@$"!`,$!`4/!!,````!`@,$!08'`!$A$A,(,10)02(5%E%A,A>!0C,8"O!Q
MD:&QP?$CLR0TM#4V=M%B-QE2<I*R0U.31&1T)765)D9F)SA8$0`!`P,#`@,&
M`P4$!@L!```!``(#$00%(1(&,0=!$PA187$B,A2!(Q61H4(6%[%2DC/PX6*B
M4W/!T?%RLN*3L],U55;_V@`,`P$``A$#$0`_`-_&B(T1=*1?M(J/?2C]4&[&
M-9NI!ZN;[*+1F@=PX6-M^*FBF)OP:(LX$QW`VQQW!.LWM9)R1\E:17:$!<3H
MIUALOY5.(`=O>CU(PH[)\0'FUR0TENQ6B=:K1K7YMC98*&L,8H"L=.1;"78J
M;@/,UD6J3M`3;<`/TU0W#V#N&N,KJ]?1$:(C1$:(C1$:(C1$:(C1$:(C1$:(
MC1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(H9=]F2AH&")B.9.
M10F[TY1K$>5,YB+E9JB#B7<IB7Q(1J0J1PWX@O\`KZG&*N47&@6?T&ZI6Y5N
MBH#;G%`%>F84>J!>84@4`.43`7CMX_@U?4%>WZ>^3/G/"YJB]<BM,XZDU(LQ
M#FYU1@I,ZSZ'64,/$1!7S*8!X`1(H;ZLR"AK[5-IT4]-6U)&B(T1&B(T1&B(
MT1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B*
MBKU#\EA<,Q-*2P6.M&X[BRL%4DQ,H16PRY4GT@=(A?%5-N9!N8-M^=$0XZOQ
M"@K[5;=U4MWO;&4O9"E0RQZ8W1I#%OXJ$33,X/9Q-\77:IK]/K%26;?Q(EXC
MR\-1#OS/<I4^50;[$<G?=_G2*B7:_1A<@MCU9X"AN5).15.5S"+\NX`*QGZ1
M6Y?:`+C].KDK:MJ/!1::%:`M<97$:(N#"!0$QA`I2@)C&'@4"AQ$1$=@``#1
M$FJU<ZM<0E#5:=CYU.%DE8B36C5O,(-9)``%9H*Y0Z*JB6_$2&,7?VZ41*;1
M$:(C1$:(JYN^GN4R-AIW3JICQ=*$=V*/?R[^P+1[5^H#=HY2:$CV)'A%FZ2A
MC*<QS\O.4-MAXZN,:""3X*#B0:)UNR_.5MSCC:2D[LDW5GJ].'AU9=FT(R;R
MR(MTW"2JC=(I6Z;U'F$%03`I1`2CR@(B(T>T#HJM-5,/4%),OGCN!Q+VTX^D
MLFYEN,=3ZK'\R2:KM0#OY>0,F=5O#P<>!@<2<J[Z8@FDF'UF$I0$P9[C?&<W
MRS)MQ."@=/>.UTT:UO0N>[HUHKJ3^%3HNK\NYEQS@N&?G>3W++:P9H"?J>ZA
M(9&WJ][J:`?B0-5GPNOK?]QV=[D^HW89VQO[0V0.*!+#9X25LUA4*<X@W?J1
M<,[:UZM$7+X)/U7&^W`X^`;-8_T^\5XY8-R/<?+")Y%?+C>V-@IU;N>"^2GM
M8&_!:9Y7U6<WY=DG8GM%@7SL&@DE8^:3W.+(R(XP=='N?TZI!2G<'^D.,%5)
MQQBB::Q3<2KK137%>&WR'1#Q(((F=S9BFWX\I^</JUD(>->F&0"!MXPS&HW&
MXN@:^VIHS]RQ5QS'UGPDW3["1L`U+1:6;A3V4#72?[R0E<]=_O1PK:$JMW,8
M'K4J=`2&DX^0KL]C6ZF1)[AU8X5%2P@HJFX]3R2J8CMRCMOK*7?ISX%G[,WO
M$LC*QI/RD2,GB]OS:;ZCV;P>M5A;'U<]T>+7XL.=XF"0@_,U\4EK-0:?+KLU
M]IC(]FBU>8[N37(="IE]9-5&#2Y5B#L[9BJL1PJT0FXYO()M5%T@*FL=$J_*
M)B@`&$-P`-:8Y.Q?C,E/CGN#GP2O832@.UQ%:'45HOHAA<G'FL1:Y>)I9'=6
M\<H:2"0'M#@"1H:5ZCJEGK@K)HT1&B(T1&B(T1&B(T1&B(T1&B(T1&B)+W:T
M,*34++;I-0$V-<A)*7<&$0#<C%JJX!,NXAN=0Q`*4/$1';50*FB'HL_G;[5Y
M/N#[E8MW.$,Z3?V1_?K8KQ4(1HS=C*"F;GX&27D%$4>4?Q#B'LU?<:,H%;&I
M6B<4DA2%`2$%$4^D*6P<G3$O)T^7PY>3AM]&N.KBS@]RE">X3S[98^)%5BBG
M,H72J.DRBGTFDDX&3:':;`4"$CI$BJ!-O#H\-<AA);KJK9T.BOWP]?F>3L9T
MV\,CD,$[!LG#M,AN;RTD1(J4DT4,&^RC9XF<AOK#5APH:*8-15..HJDB45%5
M$TB!MN=0Y4RAN.Q=Q,(`&XZHJJOGU#;Y9*QBRN-JG8W<.G8K`M'S)XEV"*[V
M/3:D5\H=PB;JD;G./O<HE$VP!OJY&-2HN.E%\?3;'_X8GQW$QC7)^)C"(F$3
M"D4PF,(CN(B(\1\1TE^NG@J,Z*Q#5M37S4531(*BRB:1"^)U#%3('ZYC"!0\
M/IT1=)C+Q<FU.]C9%B^9IJJH'=M'2+AL19`W*LF*R1S)\R1N!@WX:(NLWL=?
M=N_(-9V'<OA,<@,T))FJY$Z>_.0$"+&5$Q-N(;;AMJM#U\$2+R=A_'.7HQM&
M9!K;*<;QZIG#%=;=%VP.8`!4S9VF)5$B*%+L8NXE$/$-`YS>BI0'JNWC2LX[
MIU:^6<9-81E7X=\Y9KMH19)PDG+%*DH^!ZNFHJ921,!R"KSB)N(>`;!HXDZN
M04\%[UOMD%1*I8[K:'Z,97:I"R5@FY!<Q4TFL;%-%7CM41.8I1,"*0@4N^YC
M"`!Q'7)L;*YR5[%86;2^ZGD:QC1U+G&@_>?P&JX63R-IA\=/E,@\1V5O$Z1[
MB=`U@+B?V#0>)T6)6U7;,WK1=^$)1FLS(0>+$9:0^6XPG7&)QYBB&7,K*VAP
MQ,;RJULF(\!,"BH%,HY63;@(!P'Z`66/P/83MS)D7L9)F/+;YCM-T]R\?+&'
M=?*:?`=&@N7RLR65Y3ZHN[D6'CE?#Q\2.\MNNRWM8R2^0MZ&5S>M=7/<UO2B
MV,=O?;?A_M?QY#XUP]48VM0D6T;MW3Y-N@:=L+M%,"K2UCEP2(ZE9)VKS*',
M<>4#&'D*4.&M%N3\JSG+\H_*YR=\L[W$@5.Q@_NL;6C6CH`/#K5?3/A?!N,\
M`PL6"XS;,@M8V@.=0>9(X=7ROI5[B=23I4Z`!/OKKR[<H-]^_9SCCN]P)>JI
M8*O&.<@1U<E97&MN28HA8H*W1K%PYA4F\B1,7AXV0=$!NY;B)B'06-L7FY1#
MT+MMSO*\(Y);7MO,\8QTS6SQ%QV/C<0'U;TW`?,UW4$#6E5Y/WA[983N3P^[
MQ]Y;L=F8X'OM9@T>9',UI+`'4W;7'Y7-Z$$Z5HG/[-V,_%]I_;E&6J'?5^RQ
MV&<>L)Z$DT5FTA$RS.M1[=\P>MW)2N$7#9PF8IBG`#`(;#QUA^=RVTW-,K-9
M/;+:/OYG,>T@M<TR.(((T((.E-%G>U\5Y;]NL';Y")\-['B[9LD;P0YCVQ-#
MFN!U!!%""GNF;I4:Y(PD1/6:"AY6R2*<17XR2E&;1_-2BR9U4F$8S66(X>.C
MIIB8")E,.P:Z_!87MU%)<6T4CX(6[GN:TEK&CJ7$"@&OBNUW65QMC/%:WEQ#
M%<SOV1L<]H=(XZAK&DU<?<`E/KBK(+YJ*$2*910Y4TR!S&44,4A"A_G',(%*
M'UCH`2Z@K51+@T;G&@"3==NE1MRTRA5K-!6-6N29H:>)"2C.3&'EBH(NC1LB
M+-58&KTK=P0XIGV,!3`.W'7*NK"^L6QNO89(FRLWLWM+=S:D5;4"HJ#J-%PK
M+*8W).E;C[B&=T$FR01O#]CZ`[7;2:.H0:'6A"4BBJ:1#JK'(DD0O,=14P)D
M(4/$QCF$"E`-_$1UQ@"2&C5Q7.<YK!N<0&CQ/3]J1==R7CZWS]BJU4NE8LEC
MJ`,OFF&@YIA*/Z\,B50S`LPW9K+'8'>%1.*95`*)P(.W@.N?=XG)V-K%>WMO
M-#:3U\M[VEK7[>NTD"M*BM*TJ%B['.X;)7DV/QUU!/>VVWS61O:]T>ZNW>&D
M[=U#0&E:'V)/V[.V%J#*LH*[98Q[59J053091,];8.,D7*ZRG12229NGJ:YE
M%%?=`.7<1UR+'CF?R4+KBPLKJ:!@JYS(WN`'M)#:47"R7+N+8>Y;9Y7(V5O=
M/-&LDFC:XDZ``%P-:IU"*%5(11,Y5$U"E434(/,4Y#E`Q#$,&X&*8H[@(>(:
MPYJ#0CHNP@@@.;0M.OX)`9"RUC#$L0I/9/R#3J!"I<5).W6&+@6A0V$=^K(N
M4`$-@\0X:R6,PN7S4XML1;3W,Y_AC8YY_P!T%8;-\CP'&[8WF?O;6SM1U=-*
MR,?M<0HE#ZH78,$N2&_.@Q:*JA#'!\$\C\'(!502$%);^@IFW'F`!/N)?>\-
M=W_I!W*,'GC$7E/9L^;V_3U_<O-QW_[._<BU_7\?O/\`%Y@V=:4W_2/V]-5,
M>CY"HN2X)M9\>7&M7>O/"@9M-5>983<:L`@!@$CN/771'<H@.V^^PZZ)D,9D
M<3<&TRD$MO=-ZLD:YCA^#@"O4,5FL1G;1M_A;F"ZLG='Q/;(T_BTD)7[_7^T
M.N!3_2JR6B_6JHJ[/49R7\M8LB:`R<"G)WR5(9X0BG34+7X8Y73H^Y=S"FN^
MZ"1@X;E,._#<-7(Q4U47'1)GTV,9?"J;:<H2#;9U:I`D+!J*$W$L-#"H#M=$
MP_9!W)JG3.`<!\N&JRFIHJ-'BK.=6E-5B^I-C`)6G5?*<>V*+RK/30<\L0GO
M&A)8P'8K+GW_`"3&33Y"AP]YT.KL3B#M_A4'#2OBO,]-/)GFX"WXH?+B*T(\
M"SP2:AP#:.E3`G)-D2#Q,*4B0RQ_HZWMTD'BC3X*?>8L7,LQT60HDC.3%>92
M#N-=K2,$=%*0#X8]2>IHD4734*5-15$O-L&XAJV#M-5(BJJ*[P.V>*P;2ZK*
MQM\NUI"2G%HX&%E?I.630B;8BO6:HI))@FJ83;"/MU>:[=50(HEKV58%6R7C
MR6L!,MY9HB"5A<L5H>@6A2OL71DD0$KM8I4EBBYX[<PE'A^SJDCJ.H`%5HTJ
MK"*=@!W3Y^+G#9NS;94HP_,,)9[7'R4-($!,R8)2*!81%=<@;@;<%"F$2[B(
M\=[9=4=`I45=WJ$Q5@HUAKKB.R)D)]'W<9E[)5Z2LSM2O,SE7,)48R*;^6:M
M6I4S\@$Y3`!0`-]7(C70?4HNT^";_!4;G3N#HD1AB@3`T7'=((NK;;"FZ=H?
M&'\DJ)T6JXM.BX=\J6_*S*H5(2@)E##L4-2):TU/54%3HI#XX[`[IBO*U"NT
M=>XJR1,#+J.)7^8N(*3;MG$4]9F78)G<2B#I5)PZ`0*<Y`$`WX_9U$R`MH0J
M[36J;WOD=91Q)*UJ*B<U9)EX2Z,99V_92,HT8J(*-G":7ED5J^RABF8G15Y1
M2,0?#B(Z1T(Z:HY2M]/`3&[>$C&,)C&N=D,8QA$QC&%.-$1$1'<1$?'Z=0DZ
MJK>BBQZYV6)#&W8G98*(="W?96MM=H#LI=@,M7G8NI&<(4W$Q1$K%$H[;"(&
M$!';Q]Q]/&%CRW<:&YG;5EG`^8>YXHUG_B*UH]67(IL%VEGM+=VV;(7,<!]\
M?S/>/QVM'XJ#'Z.-B^.3KW</F-RT(,RO*5O'D2]%(HJ)PQ4%9R9;$7'<X$5D
M6S4PE#AN0-_9KT7U3YB1USB\$QWY`9),X?[50QO[`7?M7D7HBP$#;+-<F>T?
M<E\5NQU-=A!D?K[W!GQHM.VP:U&6^RYT1<;!JE$3!=SE'?7_``C?H:-O]]QF
M]9U^7GVUHQM-IU^SHKPL3(/46B4H=J[.@R=+$+U@3`BABEV*<OCKLG$<A'C.
M0VTTUM;7<;I6L,<[-\9#W-!);45('2M1[0NG<^Q,V9XI>6T%Y>6$K(7R"6U?
MY<H,;'.`#Z&C2>M*'30A8J/3ER'D/(_J1=O$IDF_W/(DTTNSIDG-7>S3-GE.
M@BBZ2*0'LR\>KD(($#W0,!0]FM^^Z6+Q>*[592'$VT%K;N@W;(HVQMK4:T:`
M*^_JOEEV2S6:S??'"W&<O+J]NFWFT/GE?*^@:[3<]SB![JK>KKYPKZ_+,MZ_
M$9?\4QV-,L4C/&=((N4K.\HUBQU%Y%EXG&2,5`5D\BU=,*K$&CT"23AP4?,*
MK'6ZP#Q#<`'6VGILFQN9EN\+D,;CI/LXA*R=T#77!<]^VAD=7Y0.@`%%HAZP
M[;,<>MK/DF*S&7B^_F,$ELRY>RU#8V!P+8F;1N))W%Q=N3V_H\)C*=IN4%%3
M&444SA,G444,)SJ'/6JX8QSG,(F,8QAW$1X[ZZ_ZGF[>:6@'08]O_N2+M?HN
M)/;N_<22[]5?KX_Y,/BO=]<C'%DA^W6<SQ6<W9KJC^,F:G5%,?5N]OH7&DG%
M2HO&\B>3K<8FU5?R#@$P-U55S@`[AR[#L%CT\Y6SGY3'QN[Q^/GC=')()GPM
M?.US:%NU[J@-'2@`^*Y/JRP=];<*EY?897*V\S)883;17#F6KF/J'%\3=NYQ
MIU+C[*46?_TYLJ=U2Q\A=K7:&D2(RCW$2L(XE\F+O@:*TFF5B.E1L#PCQ5JY
M-%J*IO><[XG,Y(4HD;DZYR&#93NGAN&@6W,>;DR8G%L>&P4J)99'-V"@(W=*
M!FC?%QV@K3CLGR+N')]YV^[;`19_-/9ONBZA@AB$AD<"6G94.U>*N%*,&X@J
MR"R_H\N<9*/7NI^ZFNVG*SLX2[MM9:I.J-7LZ4Y%P.\NCJQRLD\$RY=SKJ,!
M,(!]D=]M>5VOJ>X[%,+#]&EAPP^4%DC*M92FD0C:!IX!_P"(7N-]Z+N630G*
M'D$%QR!QWN$D,E'/ZZSF5[CK_$8R?<K>_4'[ZV/I_=NE6,1O&6/-MIAF=7H5
M?64.:-^*Q<4U;3-JDB$*1<\)"G]\A!!/S*@E3YB[CKQ#MEVZD[F<IF!+X<!#
M(9)G_P`6USB6QM\-S^E==HJ:=%LGWG[MQ=F^$6^UL<_*[B)L4$9/R;F-:'S.
M\2QA((&FXT%1JJ0.Q_T\LJ>J$O*]UW>1F"^O*._FG<;6&[9ZF>P6Y5BN`RA8
MA201=1-1IC!P`-B)-&@]=3J`3I"F)C;"=PNZ&%[0M9PW@EC;-R#8PZ0EOR15
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ML.7A^5Q`!DMY2*M=&\ZNC=UH>H!!%0"M0\Q9\\]*7<2+].N77&!N/G:-1%=P
M@T>R6.I#965`W#5I(<TT)"TM?ZT/MX^"_,/6D_A'YHGYWGG-D>G\L?/WW8_)
M^_-_>GYW_F/)]CJ^W6IO](>4?<?:TC\_]<_3*5/^9Y/W'F]/\OROGKUHMZOZ
M_P#"OM?O:R?;?RW^L[M*>5]Q]KY'_.\_\NG2JLFUY4O<UGW[P+L\S/W'OJ]!
MF,]:P3UCCZO()'YTW+_S0$?KMP\2J.)!STS?3T0UR(QM;56W:E6Q7B_X][(.
MUA[=+BHH%2P_2F?G$F!"@]G9DW1;)-&1#;@#ZP3[L`W'<J8JB<WNE'68XSQV
M_P"6Y^WP&,`^[N9-H)^EHZN>[W-:"3[>G4KK/-.78O@G%[OE.9+OL;2+<6M^
MI[B0UC&_[3W$-'LK4Z!9@IW](9[HW-_&=KV-\:1E`1<G%&B/TWKUZ[9%/LF#
MZSDY'J+PZ?$XHD!,#C[H;:W+M_3%Q!F,^WNKJ[=DR-9A1H!\=L>K2/94UIU7
MSQO/6ESQ^:^ZL[*Q9A@[_(<'.);X;I:AP)ZF@`!Z"BT9=MW<-C[U'.TJ0M\`
MQ-"#:&,W2;?6GJA';BH7>/;-UCH=8H%!TW04=-7K578.9(Y0'WBF`-2^?\)R
M';[DLF"O7"1@:'Q2`4\R-Q(:ZG@:@M(]H]E%O?VJ[DXONIQ"+D^-889=[HIH
MB:F*9H!<VOBTAS7M/BUP\055;@*WR>!^X>`6E>JQ"+LCBEVM`W`X1[QX6->$
M4#[.Z;@B2@C^*!1UU%P!93Q7H@T*T@)G353352.51)0A5$SD$#$.0X`8ARB'
M`2F*("`_1KC*ZJU?4S_T:4'_`!:Z_J*>KD?BHNZ+WO3;_P!#$]_C%]_(DTDZ
MHWHK#]6U)5">I[_:F*PX;>3FOY0-7XM`7>*@[K12-].Z):L.WQ)ZDGLYE[;.
MNW2QB\IU>F1DB@03>)TT2`/+]&XZMR?4JMZ*=NP:@I*G[U/1'Y@Q0'L&)L']
M::ZNQ]"H.4E_3O\`_KLA_C*Q?R<9J,G55;T46O6M[;\O=R7;33:]A>FRE[M=
M?R=%RJ]>AR(G>'BG$>];.GW\>HD4$69P+S<=_?#7N78'E6#XIRRXN<_<,MK.
M6T<T/=4#<'`ANE>O_0M9O5-P?D?..#6MGQBUDO,A#?->8XZ%VTL<TNU(T!I7
MXI->B#@+./;MA#+%)SAC2>QO+/,B,)R$2G2HE-,,'4.9%PLUZ*JI>5HLW`AN
M(#N<-<OU!\DX]RCD%ED./7<5W"VU+'EE?E(=4`U`Z@U7!]*7$.6<*XID<7RN
MPFL;A]ZU[!(`-[3'0D4)^DBBNUUK^MJ4:(C1$C,B1[R6Q_>HJ.;F=2$G3K/'
ML&J>W4</'L(^;-6Z>X["=990I0^L=<[%2QPY.WFE-(V3QN<?8`\$G]@6+S<,
MMSAKRVA!=-):RM:/:YS'`#\20L?OI[^GIWE8I[WL.9(R#@6XUBD5^Z/9&8L,
M@FS!BP9*%=<BZQDW)U`(85`VV#6\?<[N;P/,=OK_`!6,R4$U_);AK6-)W..F
MG1?-/LQV8[G<>[K8S.9G#W5OBH;LO?(X#:UM'"I^8GQ]BV:ZT.7U`5&/KF=M
M6<NY7%&"(+!N.IS(LM6<DV&7GF<(5`RL;&NZHJR;NW`+JH@"2KH0(&PB/-K8
M;T\\LX]Q/-9&XY#=1VL$UJQK"^M'.$E2-`?#5:F^K+@_+.<<;Q5GQ.RFO;F&
M]D>\1@$M:8P`34C0D4^*6OHE]O>9NW'MPO\`4,V4*8Q]8Y3+$E.1\5-E1*Y=
M1*L#!-4WI`045+TCN&JA0X[[EUP/4!R?`\IY3;7W'[F.ZM6608YS*T#@]Y(U
MH:T/[UE?2MPSD_">#WF-Y39RV5[)D'2-8^E2PQ1MW:$Z5:1^"=[U=L,Y.SUV
M8V;'F(ZA)WBYO+E3Y!M`1`)&>JLX]P].\<%!4Z9.1`J@;\?;K"=D,]B>-\]B
MRF;G9;V#8)6E[N@+@*#\5V+U)<8SW+^U\^%XW;27>4==0N$;/J+6DU(J1T^*
MKL]#KLESKVYY/S1>\\XFG\?/I.DQ=8JCN?2:<KI%Q,MI*5(R.BLL<BH>2(!_
M#<NX:]0]0W<#CG*<188[CE]'=1LN'22!E="&%K2:@5ZFB\5])W:KEO"<]D\O
MR['3V<K[1L41D`UW2!S]M"=?E;7IHM)G[8?O[B/[''6J=/!;R^[Q63CU@NT[
MO>[I>[5Y-XZPE>+ABRDU""K-)DV)&?P\ZJZ(/[*NSZKE,YBN98>(B7\4-;G]
MC>9]O>'\+;;Y7(6\&7N)WR2M-=VAVQUH/!O]J^=7J7[=]U>X'<5USA,5=W7'
M[6WCCA<T-VDTW2%M7`ZO)KIX!*SM_P`D^LUVX8=HV$J'V;,U*G0(UU&1"TC#
MH'?K)O)1]+N%G9TWX$.LH\D5!$P>.^N)R;%=B.5YVYY!DLZ1>W3PYVUYVU#0
MT4^7I1HHLCPS.^IS@_&+/BN*XS6PLXRUA=$TN(<]SR2?,%3N<:IXOSM_7(__
M`!I#?1_8I/#_`,0\-8+^2?3U_P#O/_Q_^5=H_J1ZKO\`^9;_`.D/_D4(.]/'
M_JQ]\T528O*W9^YBST21?R$/(UJ,:-GIBR+7RSIDX66>F$6IQ*0_*`[<Y`'7
MH7`<GV7[>33S8;.-?]PT!S7N);\IJ"/ET-*C\5Y/W2PWJ([M6UK!R#C3XS:/
M<YCHV-:[YA0M)WFH.A^(44OS`O4N^6?EG\W'(/P_[J/NDZ/,U_NI][OWN>0Y
M?.<O)\T?Q_)]GV^.NY?U,[3?>?>?JEKYOWGW'\7^9]K]K7Z?^'I7KX+SK^C?
M?7]/^P_1+WR/T_[.GR_Y7WOWFWZO^-K3I37W+;CF[(#?%^*;M=5U`35B(-X,
M<7J%(JK*.$C-X]-#GX'6!RH!@*&XB!1U\Y6BIH>B^O!T"IP["L>N<C9X4NDT
MGYQE2DG=L?N5"^XXL[]P(QP@(;"1PF^<F=!PX@F.K[W49M'10:*FJFCZJ';_
M`'/N2[+,H8_QXW6D;FP/#W.#@VYC`M85JR[%R[AD0`Q>HX<1RRQT2;&%59,A
M`+S&#;TCLYR>PXIS^SR63(;8NWQ/<>C!(*!Y]@#J5/@"2O&?4%P[*<X[6W^(
MPS7/R<9CGC8.LGE.J6#WEI<0/%P`ZE8`I"&EHF5=P,K%2$;.,7JD<\B'[)PU
ME&<@DIT5&+EBNF1PDZ35]T4S%`W-PVU]+(IX9X1<0O8^W<W<'`BA:?X@:TIX
MUK1?&V>UNK6Y=9W$;V737%KF.:0X.K0M+3\P-=*4JMMGH<]MN1,!=JDO,Y,B
M9"M3F6[DI<(JL2:1FS^-JR$8S8PSY^S4Y5F3R7,"RO2.`'!`$C"'O:^?WJ&Y
M7B^2\SCM\2]DT%C;B)TC34.D+B7`$:.#=!7I6H7U9])W!LUP[M[+=9V-\%YD
M;GSF1/T<V(,:UCBTZM+_`)C0BNW:3U2&]0C&!J9F0MRCVPMX;(K`LD95`ITT
MTK&S`R$L05!$.9XZ$A71MO#J>S7A<;@6T/4+9XBGP*M&[1\FERC@NGRZZQ5I
M>$:A59WB`&"1A$D6Y3B'VA!5F*0\P_:-OQ'5IXH5<::A1I]300#&M"_Q:Y^K
M_F28?J^G4X_%4<O>]-D1'"\]N'_K%]M_R1/K'5).JHPU;4JQ#5M350OJ>_VK
MBK_J<U_*!^[J]'])^*@[JI<=B8;=MU.#_I,K_60U"3ZE5O13"U!25/OJ??W@
MQ/\`]TV'^M-=78^A4'*2_IW\>W9`/_>5C_DHW49.JJWHGD[KL56+-/;QE7'-
M.L]AIMRGJI(_*%EJ\W)U^:C+*R3\]$&:R<2[9.T2NG:!4%`Y^44U1W#78^&9
MBUP')[/*7\44]A',WS62,:]KF'1U6N!!H#4:=1HNG=PN/WW)^&9#"XNXFMLI
M+;N,,L3W1O;*WYF4<PM-'$;3K2A-5C^]/+O^RWVF]W?R_P!T&1<H3E$EW4AB
MW),??;9:+7\B2H2:2+6R),9^2?G:$A)=L472B!.L=B93D*;<`UO%W/[:83FO
M!_NN(VMI%D6!MQ`Z&../SF[22PEC17>T_*'&@?MK1?-3LQWDY)V[[EFRY_>W
M\N)D<ZUN6W$LLOD.W4;+MD<=OEO`WEHJ6;@*Z+;U'24?,,&4K$OF<G%R+9![
M'R+!RB[8OF;E,JK=TS=-SJ(.&ZR1@,0Y3"4Q1W`1U\^Y8I8)'0S-<R9KB'-<
M""".H((J"/$'HOJS!/!=0MN+9[9+>1H<US2'-<TBH((J""-01HN]JVKJ_._\
M&W[?CJE?8B0N0G1UL>9#&(=B,@WJ%L2148.>5TUDDX-]T2D50."C=XBMRB78
M2G(8`'AK)8M@;E+7SV_EF>,FHT+=XKUZA8C-2EV$O3;._.;;3`;3J'"-U-1J
M"#^*Q'^G!W`9UEO4!PA6+KG'+LS`N\D/8B0K]DR==)6&=J<[QLE'O8N2FW+%
MV7S``4$SIF*)MM?0'NIQKCD/;3(7>.QUC'.VT#FOC@B:\=#4.:P.&GB"OE5V
M0YIRZZ[Q8G'Y7*Y&6T=?;'1R74SV.^H!KFN>6NU\"#JMU0C^H?V/IX:^=G]B
M^M@6:[](+[B;=CUIV]8WQOD6VT6S/)"TW2;/1[9/5>3<PJ;-*%9(22\!(L%5
MF9GJICIIJB("8O,7P$=;7>F;BUEE),GE\I:P7%HUL<3/-C9(T.J7$M#VG6E`
M:?`K1KUD\XR6#AP^#P=[<6F0>99GF"5\3BSY6-#BQPTK4@'XA2`]`V_7O(7:
MYD>6R!=[?>I5MF259-I.YV::M,@V9$KE>4(S;O9QZ^<H-"JJ&,"93`3F,(@&
MXB.NM>I+&X_%\PM(<;;0VT)L6DMB8UC2?,>"2&!H)I37K3X+N/H_S.7S?`+Z
MZS-W<W=PW)%H=-*^5P:(8C0%[G$"IK0>-3XIZ_6KM]MHW8G;+!2;59:;/(WF
MD((SE4G96N3"2"[IZ"Z"<G#NV3TB*X%`#D`X%,`<0'6`[!6-CD>XL-M?PPSV
MQMYB62,:]M0!0EK@14>&B[1ZI<IDL1VEGO,5<3VUX+R`"2*1T;P"75&YA::'
MQ%:'Q4#OT?#(62,D_G)R>1<E9$OR\.I1V$4E=;M9+4VCT7I)5RY.R0G9%^1J
MNJ=J0!.GRB)0V'?7H_J;QF*Q1Q4.+M+6V:_S7.\J*.,DC:!4L:*C4Z%>1>C+
M-YS/#-W.;OKV\?&(&M$T\DK6AQD)($CG`$T&HIHM*_A^M]/ZMN.M3O[5O2L5
M_K/W/N2POWO6]&"S)F:J4B\5NN6FH,Z]D2[5^O@@=B1C,-HN-C)MJP3+'R20
MD5%,A=SFW'B.M^.PN/XGR#M]`ZXL+";(6\KXY"^&)[_J):7%S2[5IJ/<OESZ
MH,MSKBG=2Y%ED\G;XJZBCFA;'<31QTV@.#6M>&_*YI!H*+1?Z47<6V[CNRS%
M\X\L#J>O-):NJ#D,\H_5D)HD_!N5?).Y!RZ55?._B<$LV5!PJ(BJIU`W,)##
MK5SO/Q=W%>?7EO'$V+'7#A-!M:&LV/&H:!0#:\.%!T%.E5NMZ>.:Q\V[76%U
M),Z;+6C3;W!>XN?YC"=I<7$N.^,L(<>IKJ:%61<!UY6O<$#^'1%Q^KQ'_+J-
M7?Z?]J5'3W_ZU55ZE^2P;15,Q4R<<JDBN:VSQ"G#E\FS,JTB4C@4VY3^;!0_
M*8-A*("&K\8\2H/]B?KL(QA\A8/93SUOTIO(;L;([$Y1*L2-(46T,V5(8H"4
MR2('.&W`04`=1D-30>"JT4"FYL'CJ"DF^>XEQ=)6-&WR&.J2]M*`@*-A=5B&
M7F$S%`0*8L@HS,YYP`>`\VX:R<>:S$-J;**ZN&V9ZL$C@W_#6BPLO'./SWPR
M<UC:.R`Z2&)A?_B+:_O3@`4I0`I0`I2@`%*```%`.`%``X`4`X`&L9JLS0=!
MT4..^;%_WBX,F'S-`%IRB+?-48)2B=<[9NF9.69H[`;;S300$>'@GXZFP_-\
M4=T4(_3:R>G"7>S8QD7)4V5R8IS4&50^Q?C<.0>LU1YC%(0'<:HJ<0`-U#IE
M#Z-3D'R@^*@TZJ6OJ%T>3M>#D9>(9KOG-.L;*8>)-TSJJ)PZZ2S1^X!-,#&,
M"*QD!'8!V+N/@&HQG6BD[I51<[%>Y;&6+J=9J7D*93K:AYD9J)DETE563]!=
M#E<H'52`XIND5B@!2\NQBCOOJ4C23HHM.T45@6&NY:IYVM=IAZ'&2RU=JK%L
MJXM+]N+5I(R#MR*)&;%+<P@FFFDH?F,;F.&P@4`WWMN:6C7Q4P:J`'J93T(_
ML>.(QA+1SV1C&$LI(LFKM%PX8E57%-/S9$CG%N<YR"`%-L;AX;:N1]->B@[K
MHI8=@UIKTA@*NPC29CEIF,D9=L]B@=H%D$52G(OQ9F4\P*8HFY@.!>40WX\!
MU"3JI-Z*<&H*2IB]2VR0$O;<;QT5,1LD]BXB;&108/$'8L3+/6Y4DG8H'4!!
M8XD'8AMC;!OMJ]&#0J#E)+TYK3`N<)KUHDJP+/Q]RG5%H<[QN62,U<-8Y9!X
MDS$X+J-E`(<`,`"`"0V^VHR#7W*K>BL+U:*DL_\`ZK'I$%[D'LCW!=N3..BL
MU"D*UWIRRA&,3DM!JW/RR3-0"=-G="$(4G.;9-Z4`*IL<"'#9;LUWO/%HV<9
MY4YS\#TAEZNMR3])_O1'K0:L.HTJ%IOZAO38.<2OYGPAC(^44K/#7:RY`'U-
M/1L_05.CQH=:%4F=O7J*]\WIP21L0W.`DW]0AGKANMB;,T3+M_@ZI3"1P2JS
M@J-Y&.024,=0$FJZC(ZH\QBFU[_R?M?V\[J0_K=E(QM_(T$7%JYI+O\`F,H6
MN)Z5<`\#0$+5GA7>GNWV0N#QK)02/QL3G#[2\8^C*:'RGZ/8`3T:2PG4M*M(
MC/TDBB%CD`F^UZWGEN0P.#QF08!&-,IQY11(\B571"<0W`PF'7C\_I5R7FDV
M^7@\CPW0N+J>^CP%L%;>M_$>0/NL#<&YIKLN&[:^ZL1(_$E-6[]43U(._*5+
MC#LYPP7&,5/*':.KY%LI)](Q4<Y,9LL[D+[*E-`5U)ES%/YEBF#L@E$2[\`#
M-1]H.U?;F#]7YU?_`'<T8J(7%H:YPU`$+?GDKTHX[3I5=<F[^][^[MQ^@=L\
M9]A!*2TSL:YSFM.E77#_`,N+;4$N8T/%#0GHK]>R'MDG.V/MRA<3WZ[O<EW.
M3?6*TY`LTBNNZ"2LUS=JR,^W;.'0B\<L$7#@Z::BPBHH'O&\=:U=P>76_+N4
MR9K'6[;2P8UD<,;13;'$-K"0-`2`"0-`MP^U7`[G@?"8N.Y:Z=>Y*1\DMQ*X
MD[Y9SND`+M2T$D`G5W4]5CM[DL3Y2]-?OZ0R*M5GKRLU?,"65<:S3MJY2K=P
MKBMB//)0WQ(A>@BX2*=1DLCU`5)R`;;8=];T<4S>&[K=MG8KS@VZGL?MYV@@
MOBD#-F[;UH31P-*%?,SG?'.1=CN\+<X+9S[*WR0N[9Y:1%-%YGF!FX:5V@L<
M.HH3[%=Q-?I$>!%*D1:F84R;.9&?-A285%VM&)1R4PL0"M43R[3KK2*!7!_>
M*@@510H;%V$P"&OL'I?Y&+W;?Y"TCQC7:R`.W%HZT::!IIT))`\5M==>M+B3
ML<'XS%7\N9>VC8G%@:'G0`O;4N%>H:T$]!0JC/U"JKW+VP*'W<]TQ0KEQ[B7
MLJ-1QQT'+,U)H-;;IIPS4\>\$SB.2<%6*=%(XBJ=,1.K[YM;$=L+SB=E]SPG
MAWYMABVM\R:H/FS/KN.X:.I2AIH#H-`M2>]..YSDVV?<?GWY.4S3GF&VH6F&
MWBH&#:=6`U&T'4CYG:FBO)_1Y<HXW#MUR#B<UB@VN3R9>G+.I77$DV1FY2NR
M=:KZ,<Z81ZIR+NT&BL*\ZADN?D#B;8`WUKQZG</E?YIMLR(I#B#9-9O#26->
MV1Y<'.Z`D/;2O5;9>C#/X+^2KSCAGB;GAD7R^47`2/C=#$&N:TZN`,;ZTK3Q
M3_\`KJW:@L.Q^T4^:M46SMLQ<J:>O5I&18'G)!V@L[<\YXHRHOBQR;;F,HL!
M`*7W>/$-=;].N/R4G<&&^MX7NLF6\N]^T[`"`/JZ;JTH*^U=P]6V5P\7:F?&
MW5Q&W(R74!CB#F^8X@N)^2N[:&U)-/9KJJZ_T=+(U*K\SW&4R>LL-#6&PITJ
M9A&$I),X]65:1YW\>Z+'@[62%XX3<R"0"FGS'V'?;;7J/JDQ60N8,7?V\,DE
MM%YK7EK2X-+@UPK0&@HTZG1>*>B?-XJRN<UB;N>**^F;`]C7N#2X-+VG;4C<
M07MT%3KT6KL./'6F*^B"JI]5WL"'O:PLT=TA%BAF_&`O)6@.79R-49]DY`AI
M>GOWG(8R:$B1(#MA-[B;H`$0XB.O9NS'<H=ON0&/(%QX]=T;,!J6$5VR@?[-
M:.\2WX+7KU#]G?ZJ\6;)B@P<KL*NMR=/,::%\)=X;J5;X!W70E9)NWWN6[K_
M`$S<QS7PN'E:9+KJ(QM^Q7D.*?-Z_;&\:L<R)'K0YD#>8:G64!N_9*`JF50Q
M2J<IC`.ZO)N)\-[M8*/SGLGA'S0W$#FE\9=_=.O6GS,>*'0D5"^<G"^<=Q.Q
M')I?)BEMK@T;<6EPQWERM:=`YNFHJ=LC""*FCJ'6]:G?I'F-%89N%[[=;DSL
M2;<GGCUFUPSF%=.>/.9BF_;@^:(>``54ZAO'CK76^]*^5;<._3<I;FU)^7S(
MW!X'A7::$_`!;;XWUNX,VK1E\)=-O0WYC%,PL)\=H>T.`^)/Q3:73UFN[+O$
M?CAGL7[?96JSMJ(>*7MKQ7YLLL$W<E,@Z?H2#-!M6:VF1NH*AG+@AEFW*!DA
MYP`=96P[#\+X-%^O]Q,FR:VA^81C\N-Y'1I!)D>:Z;1H[H1183*^IWN+W*G_
M`)8[3X:2WNK@;#*:S2Q@]2'`-BB%#7>02VE6FJF%_J\N\/Y'^4OON<^8_,/^
M[?XC\Y3/-^=1^<-]]GS)]KG_`+,_[*^-[];D_%Y.&NE?U0X-^H_>_I[=O\R^
M?M\EO_UWV/VFS_%^9Y72OO7H_P#1;N;^D_IOZJ?,_E#[;=Y\G_VWZC]]YGPV
M?D^?]5/<D-?9-SW3=UHMHLQG439[6P@(@_$4R5.*,"8N3@0QBH`K'-S&.;?;
MJ'\>.M>`-C*E;<'4K07$1;.$BHV'CTP1813!I&LD@VV3:LFZ;9`G``#@DD&_
MTCKC'4U5U>CHB-$1HBZC]DUDF3R->I%79R#5PR=H'^PLV=(G072-]2B1Q`=$
M6?KN#[?+YVT9#+:ZLG(A3PF2R],M<:"IAB%2N071BI(Z&XLW3,X@0G4V(ND'
M`1]X`Y#7;A[U;(H5//!O?YC^[136NYB!M4K*9(&;F35;F7J4V!B]-15102JA
M%]8NXJ)N`Z(;[`<=0=&X:@:*0<#H4[;K$'95:'!YY6"Q)(*/C>8%XTG6J+=8
MQAYA.1-C+HM`*(^PI`#4:R>]/E3Y55]A^H1J</3I"B04:F!>5I#/X=JF<2\P
M`=44%@.X4`!'WCB8WUZH0X]:JM0$W3O"?:[+O74D]J6/I!^^74=.WB[XCAPY
M75-SJ*JJGD#'.<QOI'52YXZU5*-*]^K8D[?Z=,MK!4JS38.::B<6TC&.^BX3
MZA#)'#<KT2G*=,X@(&`0V'42XGJJZ!/&$K%*%$H2;$X&`0]UVB(["'$-RJ;^
M&J)4'HF-5[;^W!TNN[6QO3%W+M91=RX."BBJZZQQ45554%V)CJ'.81$1X[ZE
MN=[4H"O=J^#,(TV;9V6IT:L04ZP!8&DI']1%TB5PBH@J4I_-"!B*)*&`0$!#
MCX:H7$BAZ)0)XNNA[%TOP*$_RZHJKGJ)#PZI/]V7?]H=$3<W_$.)\KM?)9*Q
MY1[VW*CT$_FFNQ$TNW2Y^IR-7;ULJZ:%$_'^*.3V_3K*XS.9G"OWXFZN+9U:
MGRY'-!^(!H?Q"P>9XUQ[D,?E9VRM+QM*?FQ,>0.M`7`EOX$)AH;T_NRB`D32
MT5VU8F0?'6*X,JK7$7R8K$-SE,#9^HZ:@`&_%`G*/M#79)^YG/[F(039:],8
M]CR/WBA_>NG6G9GM793_`'-M@<<V;=6IB#M?@XD?A2BE)7*K5ZA')PU1KT#5
MXA(1,E$UR(CH2-3,(``F(QC&[9L4P@'B!-]=.NKR[OI?/OI99IC_`!/<Y[C^
M+B2O0;''V&,@%KC8(;>V'1D3&QM_PM`'[E[^VN.N8D;=\=4+)<,>O9#IM8NT
M(<3&^%VF$CIMFFH<O(99!*0;K@W<<G`%$^4X>P=<['Y3)8F?[G%W$UO<?WHW
MN83[B6D5'N.BQF6PN'SUL;/-6MO=VO\`<EC;(T'I4!P-#[Q0IE:3V6]I^.9_
MYHI7;[BV!L`+^:3E6]58.'39R`%*5PS%\1T1DL0"ARF1`@E$-PV'78,AS[FF
M5M_M,AD[R2VI3:9'`$>PTI7\:KJN*[6]NL)>?J&+PV/AO:UWB)I(/M;NKM/L
M+:42IS+VSX&[A?@?WU8OJ^1_EL71H+YD:KN/A@O`*5T+;HN4.7K@0.;??PUP
ML#RSDG%_,_E^\FM?-IOV$#=3I6H/19#E'`^'\U\K^:L?;WWD5\OS03MW=:4(
MZINJ#V&=G^++M7LCXZP'1J=>*HL[<5^RP2$DSD8U5^Q<1CP4C$D125(X8NU$
MS$4*<@E/X;[#K+9/N1SG,X^7%97)7$^.F`#XW[2UU"'#^&HH0#H05A,/V@[:
M<?RL&<PF'M+;+6Y)CE8'AS2YI::?-0U:X@@@C5>ME#LI[5<U6UW>\K81IE\M
MSY!JU<SMA1D';P[=D@1JU0)_/R(H)(H)E*!4R%`0#CN.N/B.?\RP%BW&X;(3
MVUBTDAC"`*DU)Z5-2?%<CD':OMYRK(NR_(L3:WF2>`#)('%U&B@'U4``TH`$
MBHSTX^QZ&D&<M$=MN.HN4CG"3MA(1[64:/&;E`Y3I+MW*$F19)0AB@("40UD
M)NZ?<*XC=#/EKI\+@06N+2"#U!!;0K%0=C^TUK.RYML%8QSQN!:YH<'-(Z$$
M.J%-8A0(4I"_9(4"E#<1V*4-@#<1$1V`-=`.IKXKU0"@`'0+D0WT]RJFHR7@
MG#.9&H-,J8PI%]3*F5)-:S5V-DGR"1#&,5)O)+(?$6R0&,(\J:I2B(ZS6)Y'
MGL"_?AKRXMC6M(WN:#\6@[2?B%UW/<1XORB/R^0X^TO&@4!EB:YP'L#B-P'N
M!4=4O35[$$52+I]K^+@534!4AABG9@`Y3<P")#OS$,`#[!`0^K7:'=V.X[@6
MG,7FTBGU#_J72&]BNT+'[VX#'[@:_0[^S=12CH>*L9XN8C&8WH%.HK(Z9$E4
M:K78J#\R1/;D\VK'M4%GAB[>*ICFX>.NGY',Y;,2>;E;F>YDKH9'N?3X;B0/
MPHO0,1Q[!8"'R,'9VUG%2A$,;(ZT]NT`N_&J7VWU_P`/TZQE#[5F52IV3?`_
MSCI3R/W2=3X;-^4^`_>)S]'JH]7Y&^8OYKY;;;J>=_C^EMT^/-J^_P"E6V]5
M=9JRKB-$1HB-$7'M#\/Z_P#!HB2=YV^49[?Y7V^&.M_G/F^5=NB??XWR>_\`
M#_\`C.7CR[ZJWJA6>[,'RI\3?^5_-L^(]93K_=1]]/E>?F#^C?%__*W3_P!A
MY?W-M<F/I_%U5D_5X=/Q4<@VX_E_'_@]^GMQVY/\SZ/;JZ*^_P#<B>6E[<J/
M]*^R7Z=O'CM[=-??^Y%*&M^"/Y;P+X_OZ@[\4"?N`^P3\IXEU!53P0O@3\I[
M/][JA]R!./'^)?RGL_VOX?KU`UH?]2FWJE>S^P/VO'ZMOPZB*Z(.B4S3]\/W
M-1/4JIZ+V$_'V>W[.VWAJ3*TT5!T"]9#P#Q^S^#Q]FH'JJCJN\3[(?A_='15
C7W1^W^`=$7;T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1?_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
